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ABSTRACT
Aging of T cells is characterized by a series of alterations in surface antigen expression and a concomitant
decline in functional activity in many assays. We have extended this analysis by comparing the ability of T cells
from mice of different ages to cause graft-versus-host disease (GVHD) by using a parent into F1 model
(C57BL/6 T cells into C57BL/6C3H host animals). Young (3-5 months), adult (12-14 months), or old (19-24
months) T cells were introduced into irradiated F1 hosts. Animals that had undergone transplantation were
assessed for clinical and pathologic evidence of GVHD and for survival. At a given T-cell dose (2  106 cells),
there was a T-cell (donor) age-dependent decline in severity of GVHD, with all recipients of young T cells
succumbing to lethal GVHD, 75% of recipients of adult T cells succumbing, and no deaths occurring among
recipients of old T cells. In vivo CD4 T-cell expansion was greater for young than old T-cell groups after
transplantation, whereas old CD8 cells showed enhanced in vivo expansion compared with young cells. Among
CD4 and CD8 cells, the T-cell receptor repertoire, surface antigen expression on activated cells, and homing
receptor function were similar for all ages after expansion in vivo. The progeny of old T cells reisolated after
transplantation expressed type 1 cytokines (interferon- and tumor necrosis factor-) at a lower frequency
than young cells and had decreased cytolytic function against H-2k-bearing target cells. This provides a partial
explanation for the decreased GVHD. Carboxyfluorescein diacetate succinimidyl ester labeling of transplanted
cells showed comparable rates of proliferation when comparing GVHD-competent (12 months) and GVHD-
incompetent (19 months) T cells in both syngeneic and F1 host animals. We suggest that the lack of effector
activity demonstrated by old T cells in vivo is a reflection of a cell-autonomous defect downstream of signals
required for antigen-driven proliferation.
© 2004 American Society for Blood and Marrow Transplantation
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iNTRODUCTION
Aging is characterized by a time-dependent de-
line in the ability of an organism to respond to a wide
ariety of stressors. In the immune system, aging man- i
48fests as a decline in the ability to mount a response to
ovel pathogens or to mount a successful memory
esponse to antigens encountered earlier in an organ-
sm’s life span. The basis for the observed decline in
mmune function is complex and involves both sys-
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Old T Cells Divide In Vivo without Inducing GVHD
Bemic deﬁcits (such as the reduced production of naive
lymphocytes) and cell-autonomous defects (such as
reduced proliferative capacity or less robust activa-
ion of signal transduction machinery in response to
ntigens or cytokines).
Decreased proliferative capacity has been well
ocumented for T-cell clones from humans, in which
lonal exhaustion occurs after repeated rounds of pro-
iferation [1], perhaps triggered by progressive telo-
ere shortening [2]. In murine systems, telomere-
ependent clonal exhaustion does not seem to occur:
aseline telomere length is greater, and telomere loss
ith cell division either is not seen or is less dramatic
ecause of the constitutive expression of telomerase
ctivity in murine cells [3]. However, several studies
ave demonstrated decreased proliferative responses
f T cells isolated from aged mice, and much of the
haracterization of decreased proliferation has focused
n abnormalities of T-cell signaling (see review [4]).
any speciﬁc components in T-cell activation path-
ays have been shown to be abnormal after in vitro
ctivation of older T cells from humans and rodents.
rom proximal (early) to distal (late), abnormalities
ave been noted in clustering of co-stimulatory mol-
cules in lipid rafts [5], tyrosine phosphorylation of
-cell receptor (TCR) chains [6], kinase activity of
ap70 and Lck [7], mitogen-activated protein kinase
ctivity [8], binding of adapter molecules [9], calcium
ux [10], and subsequent nuclear factor of activated T
ells translocation [11] and nuclear factor- B activa-
ion [12]. It is not known whether the multiple abnor-
alities documented are downstream readouts of the
ame proximal defect, represent multiple independent
bnormalities of old cells, or are reﬂective of an un-
erlying change in the physiology of old T cells. In
ddition, it is difﬁcult to distinguish between a poten-
ially senescent T cell and a memory T cell, because
he surface antigenic characteristics of old T cells
verlap with those of memory cells. Independent of
urface phenotype, there is evidence that the func-
ional capacity of T cells continues to decline with
dvancing age, because naive cells from young animals
unction better than naive cells from old animals in
odels that use TCR transgenic mice [5].
As aging progresses, the diversity of the resting
ymphocyte pool also contracts, raising the possibility
hat age-related immunodeﬁciency is due to a lack of
esponding cells. This contraction stems from at least
phenomena—a decline in the thymic output of naive
ells, and clonal expansions of T cells that increase in
requency with age, particularly in the CD8 com-
artment [13-15]. The diversity of CD4 populations
lso seems to decline with age [16].
We analyzed the alloimmune responses of T cells
rom young, adult, and old donors and compared their
roliferation, cytolytic function, and cytokine secre-
ion in vitro and in vivo. In vivo we tested the ability p
B&MTf T cells of different ages to cause graft-versus-host
isease (GVHD) in the context of a complete major
istocompatibility complex mismatch and found that
ld T cells were unable to cause disease. Paradoxically,
e showed that old cells respond to mitogenic signals
ith equivalent or more rapid cell division kinetics in
ivo, yet they are unable to serve as effectors for
VHD. In assessing this lack of effector function, we
nalyzed cell-surface phenotypes, TCR repertoire,
oming activity, cytokine expression, and cytolytic
apacity of in vivo-expanded cells. Proliferation seems
o be antigen driven and distinct from homeostatic
esponses, because the kinetics of proliferation and the
egree of expansion are limited when the same T cells
re placed into syngeneic hosts. Our data suggest that
he aging process in mice differentially inhibits the
ytolytic and cytokine response of alloreactive T cells
hile maintaining their ability to proliferate in re-
ponse to alloantigens.
ATERIALS AND METHODS
nimals
T-cell donors—young (3-5 months), adult (12-14
onths), and old (19-24 months) female C57BL/6J
ice—were obtained from the National Institute on
ging contract colony (Bethesda, MD). Transplant
ecipients—female C57BL/6J  C3H (C3FEB6F1)
ice—were obtained from Jackson Laboratory (Bar
arbor, ME) or from Taconic (Germantown, NY).
one marrow donors—female C57BL/6J CD45.1-ex-
ressing mice (B6.SJL-PtprcaPep3b/BoyJ)—were ob-
ained from the National Cancer Institute (Bethesda,
D).
-Cell Purification and Phenotyping
T cells were puriﬁed by negative selection from a
ell suspension of lymph node and spleen. Cells from
animals for each age-speciﬁc group were resus-
ended in cold magnetic bead wash (phosphate-buff-
red saline [PBS], 0.5% bovine serum albumin, and
thylenediaminetetraacetic acid 2 mmol/L), and anti-
odies against B cells, granulocytes, and monocytes
ﬂuorescein isothiocyanate [FITC]-labeled anti-B220,
nti-Gr-1, and anti-Mac-1 [BD Pharmingen, San Di-
go, CA]) were added. Cells were then incubated with
nti-FITC magnetic beads (Miltenyi, Auburn, CA),
ollowed by puriﬁcation on an LS column (Milte-
yi). Preparations were tested for purity and surface
ntigen expression by ﬂuorescence-activated cell sort-
ng (FACS). FITC-labeled anti-CD4, anti-CD430,
nd anti-CD62-L; allophycocyanin (APC)-labeled
nti-CD44; phycoerythrin (PE)-labeled anti-CD8;
yChrome-labeled anti-CD8 and anti-CD4; and Fc
lock were all purchased from BD Pharmingen. A
anel of FITC-labeled murine TCR V-speciﬁc
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4ntibodies was also obtained from BD Pharmingen.
ll FACS collection was performed on a FACStar
lus machine, and data analysis was performed with
ell Quest software (BD Biosciences, San Jose, CA).
one Marrow Transplantation
Three- to 4-month-old female C3FEB6F1 recip-
ents were conditioned with 13 Gy of gamma irradi-
tion in 2 equivalent doses separated by 4 hours on the
ay of transplantation. Mice were maintained on chlo-
inated water for 3 weeks. All groups received 5  106
cell-depleted B6 CD45.1 bone marrow; GVHD
roups received 2  106 B6 T cells from young, adult,
r old donors via intravenous injection.
VHD Scoring and Pathologic Assessment
Clinical assessment of GVHD was performed
eekly by using a semiquantitative scale, as described
reviously [17]. Parameters assessed included weight
hange, activity, posture, skin integrity, and fur tex-
ure. Pathologic assessment of GVHD damage to liver
nd gut was performed on tissue specimens obtained
1 and 35 days after transplantation. Blinded samples
ere scored by 1 individual (C.L.) according to a
emiquantitative scale that measures ongoing damage,
ellular inﬁltration, and regenerative processes affect-
ng the large bowel, small bowel, and liver, as previ-
usly described [18]. Thirteen parameters were scored
o assess liver damage, whereas 15 parameters were
ssessed for the small bowel and 9 for the large bowel.
ntracellular Cytokine Assay
Spleen T cells were harvested 11 days after trans-
lantation and plated in 24-well plates in the presence
f irradiated allogeneic stimulator cells (C3H T-cell–
epleted splenocytes). Cells were cultured for 16
ours, and brefeldin A (10 g/mL) was added during
he last 14 hours of culture before antibody staining.
amples were split for surface staining with anti-CD8/
D44/CD122 or anti-CD4/CD44/CD62-L (FITC,
eridinin chlorophyll-a protein [PerCP], and APC) to
eﬁne activated subsets, followed by ﬁxation and per-
eabilization according to the manufacturer’s instruc-
ions (Cytoﬁx/Cytoperm reagents; BD Pharmingen)
efore staining with PE-conjugated antibodies speciﬁc
or murine interleukin (IL)-2, interferon (IFN)-, tu-
or necrosis factor (TNF)-, IL-4, or IL-10, fol-
owed by FACS analysis. Each data point was derived
rom pooled cells of 3 animals.
n Vitro Cytolysis Assay
Spleen T cells were harvested 11 days after trans-
lantation and enriched by positive selection with
nti-CD5 beads. Puriﬁed T cells were incubated with
104) chromium-51-labeled allogeneic (p210) or H-2dp815) tumor cells at an effector-target ratio of 50:1 c
50own to 6.25:1 to determine speciﬁc cytolytic activity.
arget cell labeling, incubations, harvesting, and data
nalysis were performed as previously described [19].
here was no speciﬁc lysis of syngeneic cells (0%-
0%) at any effector-target ratio. Spontaneous release
as 16% of total release. Each point represents the
ean 	 SD of 3 wells. Each sample represents pooled
ells from 3 animals, as described previously for the
ytokine assay.
FSE Labeling and Proliferation Assessment
T cells (prepared as described previously) were
ncubated for 15 minutes in warm (37°C) PBS con-
aining 10 mol of carboxyﬂuorescein diacetate suc-
inimidyl ester (CFSE) (Molecular Probes, Eugene
R) at a concentration of 107 cells per milliliter. Cells
ere then washed with cold PBS, spun down, resus-
ended in PBS, and kept on ice until intravenous
njection into irradiated host animals as described pre-
iously. An aliquot of labeled cells was run on FACS
o verify uniform labeling of CD4 and CD8 popula-
ions. For the experiment in Figure 6, animals re-
eived 5  106 labeled cells at the time of transplan-
ation. Spleen and lymph node cell suspensions were
tained with CyChrome-labeled anti-CD4 and PE-
abeled anti-CD8 before FACS analysis and determi-
ation of CFSE proﬁle.
tatistical Analysis
Kaplan-Meier curves were compared by using the
og-rank test for signiﬁcance; GVHD scores were
ompared by using 1-way analysis of variance
ANOVA) on data from weekly intervals. Differences
etween groups became signiﬁcant (P 
 .01) by week
and remained so throughout experiment. When
nimals died, GVHD scores for the prior week were
ncluded in subsequent analyses. Cell counts after
ransplantation were compared by using 1-way
NOVA and the Tukey posttest. GraphPad software
San Diego, CA) was used for all statistical tests.
ESULTS
omparison of Phenotype of Young, Adult, and
ld T Cells
B6 T cells were puriﬁed from spleen and lymph
ode by using a depletion technique to remove B cells
nd myeloid cells; this yielded 85% to 95% T cells
sum of CD4 and CD8). In Figure 1, cells were di-
ided into CD8 (Figure 1A) and CD4 (Figure 1B)
opulations and co-stained with CD430, CD44, or
D62-L. The fraction of CD44hi cells increased with
ge in both T-cell subsets, a ﬁnding that was consis-
ent throughout all of our experiments. High expres-
ion of CD44 has been described on both activated T
ells and memory cells, and increased expression is
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Old T Cells Divide In Vivo without Inducing GVHD
Bigure 1. Surface antigen expression on CD8 and CD4 T cells before transplantation: expression of CD44, CD430 (1B11), and CD62-L
as compared on T cells isolated from young (4 months), adult (13 months), and old (23 months) C57BL/6J mice. A, CD8 cells showed an
ge-dependent increase in CD44 and CD430 expression. CD62-L expression showed little change with age on CD8 cells. B, CD4 cells
lso showed an age-dependent increase in CD44 expression. CD430 remained low in most cells of each age group, although some
igher-expressing cells appeared in the adult and old populations. CD62-L expression was high on most young T cells, but this pattern reversed
n adult cells, of which most expressed low levels of CD62-L, a pattern that persisted in the old group. Data presented are representative of
experiments. T cells from spleen and lymph nodes of 3 animals were pooled for each age group. The line represents the position of the gate
sed to derive percentages on each plot.451B&MT
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4haracteristic of T cells from older animals, presum-
bly reﬂecting an increased fraction of memory cells.
D62-L expression was higher in young (naive) T-
ell populations but decreased with age, particularly in
he CD4 subset. By 12 months of age, the phenotypic
attern for CD62-L had been established, and little
hange was observed with increasing age. CD430 is
n activation-associated isoform of CD43 that is rec-
gnized by the 1B11 antibody [20]. CD430 expres-
ion gradually increased on CD8 cells with age (the
ntire population moved to the right), and a subset of
D4 cells showed increased expression with increas-
ng age. Recognition of CD430 by the antibody 1B11
an be used as a surrogate marker for cutaneous lym-
hocyte antigen (CLA) in the mouse, because there is
o known antibody that recognizes murine CLA. In
umans, skin homing by T cells is associated with
-selectin binding by modiﬁed P-selectin glycopro-
ein ligand-1, which is human CLA [21]. Efﬁcient
-selectin glycoprotein ligand-1-mediated E-selectin
inding is dependent on core 2 b1-6N-acetylglu-
osaminyltransferase [22], which is also required to
roduce the CD43 epitope recognized by 1B11. In
ddition to the surface antigens in Figure 1, T cells
ere also analyzed for expression of the chemokine
eceptor, CCR-7 and 4 and 7 integrins before and
fter transplantation. No difference in expression of
hese surface antigens was noted as a function of
-cell age.
n Vivo Activity of Young versus Old T Cells in a
VHD Model System: Survival
To analyze the immune response to alloantigens
n vivo, we compared the effector function of T cells
rom young (3-5 months), adult (12-14 months), and
ld (20-24 months) animals upon transplantation into
rradiated major histocompatibility complex-mis-
atched host animals (H-2b into H-2b/k). C3FEB6F1
ost animals were irradiated and underwent transplan-
ation with puriﬁed B6 T cells along with T cell-
epleted bone marrow from Ly5.1 congenic B6 do-
ors (to discriminate between T cells from B6 donors
nd T cells derived from marrow precursors). Animals
ere followed up weekly for the GVHD clinical score
see Materials and Methods), and survival was moni-
ored. The survival of animals that received bone
arrow alone (no GVHD control) and those that
eceived bone marrow plus 2 106 puriﬁed B6 T cells
f the indicated age is shown in Figure 2A. Recipients
f the oldest T cells showed no evidence of GVHD
nd survived transplantation as well as animals that
eceived only T cell-depleted bone marrow. The
urves shown are representative of 4 experiments and
how signiﬁcant differences in survival between recip-
ents of young and old T cells, as well as of adult and
ld T cells. n
52VHD Clinical Score and GVHD-Specific
athology
To provide a clinical correlate for the survival
ata, weekly assessment for GVHD of animals who
ad undergone transplantation was performed with an
stablished index (see Materials and Methods). Con-
istent with the survival data, by 3 weeks after trans-
lantation, recipients of old T cells had signiﬁcantly
ower GVHD clinical scores than recipients of young
r adult T cells throughout the period of observation;
he scores were equivalent to those of the marrow
ontrol group (Figure 2B). Histopathologic changes in
VHD target organs were compared at 3 weeks after
ransplantation by examination of liver and bowel with
n established scoring system (see Materials and
ethods). In contrast to the clinical assessment and
urvival data, recipients of old (22 months) T cells
howed evidence of pathologic change when com-
ared with control animals that received only T cell-
epleted marrow. Differences in histopathology
cores between groups that received T cells were not
tatistically signiﬁcant (Figure 2C).
omparison of T-Cell Expansion In Vivo
On day 11 after the infusion of 106 B6 T cells
nto irradiated C3FEB6F1 hosts, the spleen and
ymph nodes of recipients of old T cells were larger, as
eriﬁed by total cell counts (Table 1). Donor T-cell
ounts in the spleen were not signiﬁcantly different
mong young, adult, and old animals. A total of 8 to
0  106 donor T cells were recovered, on average,
rom each spleen. In lymph nodes, the total cell count
nd donor T-cell count were signiﬁcantly different
hen comparing adult and old (P 
 .05) and young
nd old (P 
 .001) T-cell groups; the older cells
enerated more progeny (1-way ANOVA). Combin-
ng the donor T-cell counts from spleen and lymph
odes (8 nodes per animal), we can document a min-
mum expansion of 12- to 14-fold over the input
umber of donor T cells. Table 1 shows the ratio of
D4 to CD8 cells before transplantation and on day
11 in spleen and lymph nodes from recipients of the
ifferent ages of T cells. The ﬁnal columns in Table 1
how the expansion of donor CD4 and CD8 cells
ecovered for each of the input T-cell ages. For all
ges, CD8 cell expansion was greater than CD4 ex-
ansion. The oldest T cells showed greater CD8 ex-
ansion than young cells (34-fold versus 24-fold).
onversely, young CD4 cells underwent greater ex-
ansion (5.6-fold) than old CD4 cells (4.1-fold).
hese expansion ﬁgures represent minimum bound-
ries, because they were calculated on the basis of T
ells recovered from spleen and lymph nodes and are
ot an estimate of total body T cells.
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Bigure 2. In vivo activity of young, adult, and old T cells in allogeneic bone marrow transplantation. A, Comparative survival of recipients of 2 106 T
ells from3-month-old (), 12-month-old (Œ), or 24-month-old (E) donors or bonemarrow alone (). All animals received 5 106T cell-depletedmarrow
ells from B6 CD45.1 congenic mice. Animals that received marrow alone (n 4) all survived, as did animals that received old T cells (n 8). All animals
hat received youngT cells (n 8) died of GVHD, whereas 75% of animals (n 8) that received adult T cells died of GVHD.This curve is representative
f results from 5 separate transplantations. Differences between young and old (P
 .01) and adult and old (P
 .05) groups were signiﬁcant (log-rank test).
,GVHDindex (clinical score): weekly assessment of clinicalGVHDwas performedby using a scoring system composed ofweight change, posture, activity,
rooming, and skin condition, as described in Materials and Methods. GVHD was severe in recipients of young T cells () and intermediate in recipients
f adult T cells (Œ). Animals that received noGVHD-inducingT cells () and animals that received oldT cells (E) had similarly low clinical scores. GVHD
cores were compared by using 1-way ANOVA on data from weekly intervals. Differences between groups (young versus old and adult versus old) became
igniﬁcant (P
 .01) byweek 3 and remained so throughout the experiment. C,Histopathology index frommice killed at day21.No signiﬁcant differences
ere noted between experimental groups (n  4 animals per group).453B&MT
T
E
C
C
T
o
c
C
(
e
l
s
m
t
e
8
c
C
c
a
c
T
T
G
l
e
u
c
(
C
s
p
a
p
t
c
g
p
c
o
c
W
w
1
w
c
w
s
f
t
T
C
a
p
v
(
(
c
c
a
I
t
T
Y
A
O
C
J. S. Friedman et al.
4-Cell Phenotype and Function after In Vivo
xpansion
Figure 3 shows expression of CD44, CD430, and
D62-L determined 8 days after transplantation. For
D8 cells (Figure 3A), there was a convergence of
-cell surface antigen expression, regardless of the age
f the responding cells, toward an activated phenotype
haracterized by high expression of CD430 and
D44 and low expression of CD62-L. For CD4 cells
Figure 3B), phenotypes also converge toward high
xpression of CD44, high expression of CD430, and
ow expression of CD62-L for young and adult re-
ponding cells. Among the old responding T cells,
ost cells assumed the same activated phenotype, al-
hough the percentage of activated cells was lower for
ach marker: 63% CD44hi positive old cells versus
3% positive young cells; 58% CD430 positive old
ells versus 81% positive young cells; and 42%
D62-L positive old cells versus 21% positive young
ells. This suggests a subpopulation of old cells that
re phenotypically less activated than their younger
ounterparts.
CR Repertoire: V Expression before and after
ransplantation
Another possible explanation for the lack of
VHD effector activity in older cell populations is a
ack of alloreactive cells due to the loss of TCR rep-
rtoire diversity. We assessed TCR V expression by
sing a panel of antibodies against 15 V families in
onjunction with staining for CD4 and CD8. Figure 4
CD4 before and after transplantation [Figure 4A];
D8 before and after transplantation [Figure 4B])
able 1. Donor T-Cell Posttransplantation Expansion
T-Cell Donor Age
Before
Transplantation
S
(Da
oung (5 mo)
CD4/CD8 ratio 1:0.7
Total cells (average) 48.4 
No. T cells (average) 9.9 
dult (14 mo)
CD4/CD8 ratio 1:0.7 1
Total cells (average) 53.3 
No. T cells (average) 8.4 
ld (21 mo)
CD4/CD8 ratio 1:0.5 1
Total cells (average) 62.9 
No. T cells (average) 8.4 
ells were harvested from spleen and lymph nodes of C3FEB6F1 h
group). The total cell count and donor T-cell count were signiﬁ
young (†P 
 .001) groups, whereas differences in spleen cell co
each group after transplantation (average value from 6 animals)
the minimum expansion of CD4 and CD8 cells was calculated
from spleen and lymph nodes by the number of input CD4 or
compared by one-way ANOVA with the Tukey posttest.hows V expression proﬁles before and after trans- I
54lantation (day 11) for T cells from young, adult,
nd old animals. Some V families that showed ex-
ansion (or contraction) on transplantation in animals
hat got GVHD (young or adult) also expanded (or
ontracted) to a similar degree in animals that did not
et GVHD (old). We looked for conservation of a
attern of response by measuring the direction of
hange in expression for each V (increase, decrease,
r no change) before and after transplantation and
ompared this change for each T-cell age group.
hen comparing young and adult T cells, changes
ere concordant (in the same direction) for 11 of the
5 V groups tested (for both CD4 and CD8 cells),
hereas changes were concordant for only 6 (CD4
ells) and 7 (CD8 cells) out of 15 V groups tested
hen comparing young and old T cells. Although
uggestive, these data are not signiﬁcantly different
rom results expected by chance (P  .07 with a 2
est).
-Cell Effector Function: Cytokine Expression and
ytolytic Activity of In Vivo-Expanded Cells
We next characterized the effector function of old,
dult, and young T cells recovered after in vivo ex-
ansion. Day 11 activated splenic T cells were har-
ested and tested for intracellular cytokine expression
Figure 5A). Fewer activated CD4 T cells from old
24 months) mice expressed the GVHD-inducing Tc1
ytokines IFN- and TNF- compared with young
ells (5 months) or adult cells (14 months). In contrast,
similar fraction of activated CD4 cells expressed
L-2, independent of age. In activated CD8 popula-
ions, a similar pattern was observed; the fraction of
Lymph Nodes
(Day 11)
Minimum Estimate-Fold
Expansion
1:2.7 Donor (B6)
106) 3.9  0.3 (106) CD4 CD8
106) 3.4  0.3 (106) 5.6 24
1:5.1 Donor (B6)
106) 5.2  1.3*(106) CD4 CD8
106) 4.5  1.1*(106) 3.9 25.8
1:3.8 Donor (B6)
106) 7.0  1.3†(106) CD4 CD8
106) 6.0  0.9†(106) 4.1 34
day 11 after transplantation with 106 B6 T cells (6 animals per
reater in lymph nodes of old versus adult (*P 
 .05) and old versus
re not signiﬁcant. CD4/CD8 ratios before transplantation and for
isolated from spleen or lymph nodes are presented. An estimate of
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Bigure 3. Surface antigen expression on CD8 and CD4 T cells after transplantation: 8 days after transplantation, T cells were reisolated from
pleen and lymph nodes of 3 animals that received the indicated ages of T-cell inoculum (from the same experiment as shown in Figure 1).
, CD8 T cells were reanalyzed for the expression of CD44, CD430, and CD62-L. Cells from each age group showed an activated phenotype
haracterized by a high expression of CD44, high expression of CD430, and low expression of CD62-L. B, CD4 T cells from young and adult
roups also displayed an activated phenotype characterized by high expression of CD44, high expression of CD430, and low expression of
D62-L. However, among T cells in the 23-month-old group, a subset of cells expressed less CD44, less CD430, and more CD62-L. Data
n this ﬁgure are representative of cells reisolated from 3 separate transplant experiments between days 7 and 14. Each sample represents
ooled cells from 3 animals. The line represents the position of the gate used to derive percentages on each plot.455B&MT
F
t
a
a
m
o
J. S. Friedman et al.
4igure 4. TCR V expression proﬁles in young, adult, and aged mice before and after transplantation. A, CD4 cells before and after
ransplantation. B, CD8 cells before and after transplantation. T cells isolated from spleen and lymph nodes of animals of the indicated
ge were stained with antibodies against CD4 (CyChrome), CD8 (phycoerythrin), and a panel of FITC-labeled TCR V-speciﬁc
ntibodies that recognize V 2, 3, 4, 5, 6, 7, 8.1, and 8.2 (labeled 8 in the ﬁgure), 8.3, 9, 10, 11, 12, 13, 14, and 17. Data are presented as the
ean percentage (	SD) of cells (CD4 or CD8) positive for the speciﬁc V from 3 separate experiments. In vivo-expanded cells were isolated
n day 11.56
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Old T Cells Divide In Vivo without Inducing GVHD
Bhereas IL-2 expression was similar. Expression of
L-4 and IL-10 was low in all groups, as was TNF-
xpression in CD8 cells of all ages (data not shown).
Effector activity was also assessed in day 11 T
ells by measurement of cytolytic activity against an
lloantigen-bearing tumor cell line (Figure 5B). Al-
hough adult T cells demonstrated effective and spe-
iﬁc cytolysis, there was little activity in the old T-cell
opulation. As with the cytokine data, these results
elp to provide a partial explanation for the lack of
VHD morbidity and mortality in recipients of old T
ells. There is no indication of a differential role for
as/Fas ligand in cytotoxicity in this system, because
xpression of Fas was comparable on T cells from each
igure 5. Effector function of transplanted T cells. A, Intracellular
ytokine expression in activated CD4 and CD8 T cells: T cells (B6)
ere isolated and pooled on day 11 from spleens of mice that had
ndergone transplantation (C3FEB6F1). Cytokine expression was
etermined by FACS after overnight incubation in the presence of
rradiated stimulator cells (C3H B cells) and brefeldin A. A higher
raction of activated CD4 cells (CD62-L negative and CD44 high)
rom young (5 months) and adult (14 months) animals expressed
NF- and IFN- than did old CD4 cells. IL-2 expression was
imilar for all groups. Activated CD8 cells (CD44 high and
D122) from 14-month-old animals expressed more IFN- than
ld CD8 cells, whereas IL-2 expression was again similar. Each data
oint is a single FACS analysis that used pooled cells from 3 donor
nimals. B, Cytolytic activity of freshly isolated progeny of adult (14
onths) and old (24 months) T cells isolated at day 11 after
ransplantation was assessed by incubating puriﬁed T cells with
hromium-51-labeled allogeneic target cells (p210 leukemia line;
-2k) for 4 hours, followed by determination of speciﬁc chromium
elease. Adult T cells efﬁciently lysed allogeneic target cells over a
ange of effector-target ratios, whereas old cells had little activity at
ny concentration. Each data point represents the mean 	 SD of
riplicate determinations; each curve was made with pooled cells
rom 3 animals.ge group, whereas expression of Fas ligand was not h
B&MTetectable above background on T cells from any age
roup (data not shown).
FSE Comparison of Homeostatic versus
lloantigen-Driven Proliferation in Young
nd Old T Cells
Homeostatic expansion of both CD4 and CD8 T
ells has been well documented in host animals lacking
cells [23,24], and homeostatic proliferation is
hought to play a role in the maintenance of T-cell
umbers during aging, when production of naive T
ells is greatly reduced. It is possible to discriminate
etween homeostatic proliferation and antigen-driven
esponses by comparing the kinetics and degree of
xpansion of a given cell population when transferred
nto syngeneic versus antigen-mismatched hosts [25].
igure 6 compares the proliferative responses of 12-
onth-old (GVHD-inducing) and 19-month-old
non-GVHD-inducing) T cells in syngeneic hosts (in
hich homeostatic expansion is predominant) with
roliferative responses of the same T cells in alloge-
eic hosts (in which homeostatic and antigen-driven
ignals are both present) 64 hours after transplanta-
ion. Expansion of CD8 T cells in both age groups was
omparable under both homeostatic and antigen-
riven conditions, although 19-month-old T cells
roliferated slightly faster (Figure 6A). Little CD4 cell
roliferation was seen upon adoptive transfer to syn-
eneic hosts; in allogeneic hosts, a similar fraction of
apidly dividing CD4 cells was seen in both groups
Figure 6B).
ISCUSSION
T cells from old mice have poor effector function
oth in vitro and in vivo when measured by a variety
f assays—including cytokine expression in activated
ells, ability to lyse alloantigen-bearing target cells,
nd ability to cause GVHD—when compared with T
ells from younger animals. Surprisingly, this lack of
ffector function is not secondary to a failure to pro-
iferate (in vivo) but occurs despite vigorous prolifer-
tive responses, as measured by recoverable cell
ounts in vivo. In T-cell ablation studies, residual or
ransplanted T cells can undergo homeostatic prolif-
ration, in which a peripheral antigen-independent
xpansion occurs in response to a T-cell deﬁcit. Rates
f proliferation of cells undergoing homeostatic ex-
ansion are slower than for those undergoing antigen-
riven expansion, and cells express lower levels of
ctivation antigens [25]. In our model, we have the
otential for both homeostatic and antigen-driven
roliferation of transplanted T cells. Parallel trans-
lantation of identical young, adult, and old T-cell
opulations into irradiated congenic and allogeneic
osts demonstrates more rapid T-cell expansion in
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J. S. Friedman et al.igure 6. Proliferation of transplanted cell in syngeneic and allogeneic hosts. A, Proliferation of CD8 T cells. CFSE-labeled T cells (CD4 and
D8) were injected into irradiated C3FEB6F1 (Allo) or CD45.1 congenic (Syn) mice and harvested 2.5 days after transplantation. Sufﬁcient
D8 cells were obtained from both spleen and lymph nodes to compare the proliferative responses of adult (12 months) and old (19 months)
ells. B, Proliferation of CD4 T cells. Labeled T cells recovered from spleen showed little proliferation in syngeneic hosts, whereas a peak
epresenting rapidly dividing cells was present in both the adult and old T cell groups in C3FEB6F1 (Allo) host animals. Similar results were
btained at 48 hours after transplantation, but by 96 hours after transplantation, the CFSE signal on rapidly dividing cells was lost (data not
hown). Percentages reﬂect the fraction of CFSE-positive CD4 cells in a rapidly dividing population (left) or slowly dividing population (right).
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Old T Cells Divide In Vivo without Inducing GVHD
Bllogeneic host animals, suggesting that we are pri-
arily observing an antigen-driven process (Figure 6).
The differences that we observed in effector func-
ion could be due to the loss of a critical subset of cells
ith age (eg, a hole in the repertoire) or to a more
ubtle cellular alteration that preserves T-cell activa-
ion and proliferation, but not function. We have
ompared several phenotypic characteristics that have
een used to differentiate young and old T cells. After
ransplantation (day 7 to day 14), there is a con-
ergence in expression of these markers on cells of all
ges. The predominant phenotype includes high ex-
ression of CD44 (on CD4 and CD8 cells), low ex-
ression of CD62-L (especially on CD8 cells), and
igh expression of CD430 on both CD4 and CD8
ells. A subpopulation of old CD4 cells diverges from
his predominant phenotype (Figure 3B), expressing
ower levels of CD44 and CD430 and higher levels of
D62-L; this is suggestive of less robust activation (or
ermination of response) of some old CD4 cells.
Differences in the ability of young and old cells to
igrate into target tissues do not seem to play an
mportant role in the lack of effector activity of older
ells, because early steps in lymphocyte homing (in
itro tethering and rolling) are not different between
roups (data not shown). Defects in later stages of
issue homing are also not a likely explanation for our
esults, because pathologic analysis of liver and gut
pecimens (day 21) revealed similar degrees of lym-
hocyte inﬁltration regardless of T-cell age.
The potential of reduced T-cell diversity in older
opulations as an explanation for our results was as-
essed by using a panel of TCR V-speciﬁc antibodies
Figure 4). Although there were differences between
roups in V expression both before and after trans-
lantation, T-cell pools from young, adult, and old
onors demonstrated similar patterns and kinetics of
roliferation in response to the environment (stimu-
ation) encountered during transplantation, thus mak-
ng it unlikely that an absence of alloreactive cells in
he old T-cell population explains their failure to
ause GVHD. Speciﬁc differences in V expression
etween groups, such as a higher percentage of V-
-positive young CD4 cells, could still play a role in
he observed differences in GVHD activity, and
igher-resolution mapping of TCR diversity could
eveal a lack of a speciﬁc and critical subpopulation in
lder T-cell preparations.
In this parent into F1 transplant model, although
oth CD4 and CD8 cells can serve as effectors of
VHD [19], CD4 cells seem to play the predominant
ole as producers of GVHD-inducing cytokines. In-
racellular staining for IFN- and TNF- from acti-
ated CD4 T cells isolated after transplantation re-
ealed that a higher fraction of in vivo-expanded
oung/adult cells expressed these effector cytokines
han did old T cells, whereas IL-2 expression was
B&MTimilar for all groups. The cytolytic activity of recov-
red in vivo-expanded T cells demonstrated speciﬁc
ctivity of adult T cells, with less activity of old T cells
gainst an H-2k-bearing allogeneic cell line (p210).
his was consistent with a lack of in vivo GVHD.
Our in vivo studies demonstrate that old (19
onths) T cells are capable of both homeostatic and
ntigen-driven proliferation upon adoptive transfer at
ates comparable to those of transferred young (3-5
onths) and adult (12-14 months) cells. Despite com-
arable proliferation, the progeny of old T cells have
educed effector function in vivo (as measured by the
bility to induce GVHD) and in vitro.
Our results, which focus exclusively on the role
-cell donor age plays in GVHD induction, do not
gree with a recent study that found increasing donor
ge to be a signiﬁcant risk factor for GVHD in clinical
ransplantation [26]. In this study, all animals received
common T cell-depleted marrow inoculum from
oung B6 CD45.1 congenic animals plus puriﬁed T
ells from different ages of donor B6 mice—thus, all
econstituting cells, with the exception of T cells, were
erived from a young donor. In prior work, we have
hown that marrow-derived APCs from older mice are
ore effective at inducing GVHD [27]. Thus, a pos-
ible explanation for the discrepancy between our
ndings and clinical experience is that GVHD in
ecipients of older marrow is related to enhanced APC
unction of older cells, which may compensate for
ecreased T-cell function.
In summary, our results suggest that in addition to
reviously described in vitro defects in the activation
f old T cells, there are distinct functional defects in
ivo downstream of successful activation and prolifer-
tion. It remains to be determined whether this is due
o cell-autonomous changes resulting from aging,
uch as increasing mitochondrial dysfunction de-
cribed in other tissues [28], or whether it is in some
ay related to selective pressures during aging for T
ells capable of self-maintenance.
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